We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Cardiac Problems Linked to Alzheimer's Disease Progression

By HospiMedica staff writers
Posted on 03 Dec 2007
A new study suggests that Alzheimer's disease (AD) may progress more rapidly in people with high blood pressure or atrial fibrillation, a form of irregular heartbeat.

Researchers at the Johns Hopkins University School of Medicine (Baltimore, MD, USA) and other institutions examined 135 men and women over the age of 65 who were newly diagnosed with AD. More...
All had undergone annual memory tests for an average of three years. The study participants were part of a study on memory health and aging, which has been following a group of 5,092 people 65 or older living in Cache County (UT, USA) since 1995.

"What makes this group and study unique is that we have been following these participants in the community for over a decade, even before they were first diagnosed with AD, so we know a good deal about their medical history,” said lead researcher Michelle M. Mielke, Ph.D., of the department of psychiatry and behavioral sciences. "Studies that enroll AD patients only from clinics may miss key factors, such as date of onset and history of cardiovascular disease and treatment.”

The study results showed that ten patients with high blood pressure (defined as systolic pressure over 160) at the time of AD diagnosis showed a rate of memory loss roughly 100% faster than those with normal blood pressure. A further ten patients with atrial fibrillation at the time of the diagnosis showed a rate of memory decline that was 75% faster than those with normal heartbeats. The study was published in the November 6, 2007, issue of Neurology.

"The possibility that specific vascular conditions may affect how fast a person with AD declines provides new opportunities for slowing the rate of AD progression,” said Dr. Mielke. "Treatments for atrial fibrillation and high blood pressure are relatively inexpensive and safe and may reduce memory decline in AD patients with these conditions.”


Related Links:
Johns Hopkins University School of Medicine

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.